Evidence map›Paper›PMID 31149518›Full record

ArticleInternational cancer conference journal2018

Successful radiotherapy for endometrial serous carcinoma with local repeated recurrence.

Shinya Kusumoto, Hisaya Fujiwara, Maiko Sagawa, Takahiro Nobuzane, Toshihiro Nishida, Yukio Akagi, Yutaka Hirokawa, Yasuhiro Katsube

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shinya Kusumoto1Department of Obstetrics and Gynecology, Chugoku Rosai Hospital, 1-5-1 Hiro Tagaya, Kure, Hiroshima 737-0193 Japan.ORCID 0000-0002-4551-6719
Hisaya Fujiwara1Department of Obstetrics and Gynecology, Chugoku Rosai Hospital, 1-5-1 Hiro Tagaya, Kure, Hiroshima 737-0193 Japan.
Maiko Sagawa1Department of Obstetrics and Gynecology, Chugoku Rosai Hospital, 1-5-1 Hiro Tagaya, Kure, Hiroshima 737-0193 Japan.
Takahiro Nobuzane1Department of Obstetrics and Gynecology, Chugoku Rosai Hospital, 1-5-1 Hiro Tagaya, Kure, Hiroshima 737-0193 Japan.
Toshihiro Nishida2Department of Pathology, Chugoku Rosai Hospital, 1-5-1 Hiro Tagaya, Kure, Hiroshima 737-0193 Japan.
Yukio AkagiHiroshima Heiwa Clinic, State of the Art Treatment Center, 1-31 Kawara-machi, Naka-ku, Hiroshima, 730-0856 Japan.
Yutaka HirokawaHiroshima Heiwa Clinic, State of the Art Treatment Center, 1-31 Kawara-machi, Naka-ku, Hiroshima, 730-0856 Japan.
Yasuhiro Katsube1Department of Obstetrics and Gynecology, Chugoku Rosai Hospital, 1-5-1 Hiro Tagaya, Kure, Hiroshima 737-0193 Japan.
Chugoku Rosai Hospital · JPKawamura Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of endometrial serous carcinoma (ESC) has been increasing, and ESC is resistant to treatment. We report a patient with ESC who responded to radiotherapy for multiple recurrences. The first recurrence was detected in the vaginal wall and left internal iliac lymph node 5 months after the initial treatment. Concurrent chemoradiotherapy (CCRT) was administered. Radiation was delivered using the intensity modulated radiation therapy technique. The second recurrent tumor was detected in the right internal iliac lymph node after 4 months, and CCRT was conducted. After 4 months, the third recurrence was detected in the right common iliac node, and CCRT was performed. After 8 months, the fourth recurrence was detected in the horizontal portion of the duodenum, and radiotherapy was administered. After 9 months, the fifth recurrence was detected in the vaginal wall. Interstitial brachytherapy was conducted. Grade 2 gastrointestinal injury, nausea and radiodermatitis were observed. During the subsequent 13-month follow-up, there has been no recurrence. Although ESC is resistant to treatment, radiotherapy could be effective in some cases. Even when multiple recurrences occur, radiotherapy may be considered a treatment option if the irradiation level is permissible.

Indexed as

Complete remissionEndometrial serous carcinomaIntensity modulated radiation therapyMultiple recurrence

Identifiers

PMID31149518
PMCPMC6498359
OpenAlexW2795928105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.